Skip to main content
American Journal of Clinical and Experimental Immunology logoLink to American Journal of Clinical and Experimental Immunology
. 2016 Mar 23;5(1):33–40.

Inflammasome, IL-1 and inflammation in ozone-induced lung injury

Chloé Michaudel 1,2, Aurélie Couturier-Maillard 2, Pauline Chenuet 2, Isabelle Maillet 2, Catherine Mura 2, Isabelle Couillin 2, Aurélie Gombault 2, Valérie F Quesniaux 2, François Huaux 4, Bernhard Ryffel 2,3
PMCID: PMC4858604  PMID: 27168953

Abstract

Exposure to ambient ozone causes airway hyperreactivity and lung inflammation, which represent an important health concern in humans. Recent clinical and experimental studies contributed to the understanding of the mechanisms of epithelial injury, inflammation and airway hyperreactivity, which is reviewed here. The present data suggest that ozone induced oxidative stress causes inflammasome activation with the release of IL-1, other cytokines and proteases driving lung inflammation leading to the destruction of alveolar epithelia with emphysema and respiratory failure. Insights in the pathogenic pathway may allow to identify novel biomarkers of ozone-induced lung disease and therapeutic targets.

Keywords: ROS, NLRP3 inflammasome, IL-1, IL-17, DAMP, airway hyperreactivity

Background

Ozone (O3) is a highly reactive molecule causing oxidative damage leading to cell death. Oxidative stress is likely a major mechanism causing cell and tissue injury with an acute respiratory inflammatory response. Long term exposure to ozone due to environmental pollution causes chronic morbidity and mortality with enhanced responses to microbial or allergen challenges [18,33,37].

Recent investigations revealed that cellular injury generate danger associated molecular patterns (DAMPs) such as adenosine triphosphate (ATP), uric acid (UA) crystals, hyaluronic acid (HA), heat shock protein (hsp) 70 and other DAMPs which activate PPRs such as NLRs or TLRs, see recent reviews on DAMPs, PPRs such as NLRs and TLRs.

TLR2 and TLR4 signalling appear to be involved in ozone-induced inflammation [58]. TLR4 activation might be mediated by HA, a degradation product of matrix components and hsp70, known TLR4 agonists [5,35,36]. Downstream, the TLR adaptor proteins MyD88 and TIRAP are required for the inflammatory response [35] activating NFκB-dependent inflammatory gene expression.

IL-1β is a potent inflammatory mediator which is induced by bacterial infection and tissue injury including ozone [10]. IL-1β production relies on activation of the inflammasome complex, which may be promoted by ozone directly or via injury-induced endogenous NLRP3 activators. Activation of caspase-1 and mature IL-1β production and airway hyperreactivity has been reported to be NLRP3 dependent but however not confirmed [13].

Ozone-induced respiratory effects in rodents

It may be important to revisit the functional, inflammatory and morphological effects of ozone in the experimental mouse model, reflecting what may happen in man [39].

Acute exposure leads to lung injury affecting the respiratory epithelial barrier with release of inflammatory mediators and neutrophil recruitment [41]. The claudin protein family are involved in the formation of the intercellular tight junctions controlling paracellular fluid exchanges. Claudin 18, exclusively expressed in alveolar epithelium, and claudin 4 are critical for homeostasis and involved in lung inflammation [51].

The respiratory epithelium represents the first structure exposed to ozone, but other cells in the lamina propria such as macrophages, dendritic cells, innate lymphoid cells and T cells, vascular endothelium, fibroblasts and smooth muscle cells are likely targets of the reactive species generated by ozone. Epithelial cell damage with disruption of the tight junctions [42] causes protein leak into BALF, the release of a variety of mediators such as IL-1α and IL-1β, IL-25, IL-33, TSLP, leukotrienes and prostaglandins, and chemokines which attract neutrophils, monocytes, lymphocytes and other cells.

Chronic ozone exposure such as twice weekly 2-3 part per billion (ppm) for 3 h causes repeated bouts of inflammation with progressive destruction of alveolar epithelial cells and emphysema within 6 weeks, resembling in part to that found in COPD [47,55].

Inflammasome and interleukin-1 - key players in inflammatory response

The immediate immune response, known as innate immunity, is triggered by endogenous or environmental dangers or injury events through the NLRP3 inflammasome complex. The NLRP3 inflammasome is a cytosolic multiprotein complex which is activated in response to signals derived from tissue injury, metabolic changes and infection [2,17,32,53,54,56,57]. Activation of the cytoplasmic NLRP3 protein induces the formation of a multimeric complex containing the adaptor protein ASC and the effector protein caspase-1 [1,16,27]. Activated caspase-1 cleaves inactive pro-IL-1β and pro-IL-18 precursor proteins to their biologically active forms. The regulation of the cytokine IL-1β needs a tight control as it plays an essential role in systemic inflammation and neutrophil recruitment [10,34]. It is now accepted that two signals are necessary for IL-1β production (Figure 1): first, the production of pro-IL-1β and NLRP3 is regulated via TLR ligation, and second, inflammasome oligomerization, caspase-1 recruitment and activation, and caspase-1-dependent cleavage of pro-IL-1β releases biologically active IL-1β. This second signal may be induced by a broad variety of molecules classified either as pathogen-associated molecular patterns (PAMPs) produced by microbes/pathogens or DAMPs induced by injury. Environmental pollutants such as silica and other particles including nanoparticles and fibres such as asbestos [11,19], aluminum salt (alum) adjuvant [8] represent exogenous DAMPs. Endogenous DAMPs originate from metabolic stress such as high concentration of cholesterol, glucose, amyloid-β protein, ATP, or UA crystals as reviewed recently [16].

Figure 1.

Figure 1

Mechanism of inflammasome activation. Pollutants, nanoparticles and allergens cause epithelial injury with loss of the epithelial integrity and release of endogenous DAMPs such as HMGB1, UA, ATP and others, leading to inflammasome activation and IL-1β secretion.

NLRP3 inflammasome activation occurs through two major mechanisms: plasma membrane rupture (for bacterial toxins and ATP) or phagocytosis of particles [9,44]. Extracellular ATP (eATP) or toxins from different sources cause cellular K+ efflux and pore formation [45]. Particles including silica, alum, fibrillar amyloid-β protein, or UA crystals cause lysosomal destabilization and rupture with the release of the lysosomal proteases such as cathepsin B into the cytoplasm with increased K+ efflux and reactive oxygen species (ROS) production. Recently, we described mechanistic links between ATP release and particle-mediated inflammasome activation pathways [49,50].

Role of reactive oxygen species (ROS)

Since ozone generates reactive oxygen species, a direct activation of the inflammasome by ozone is likely to occur. However endogenous danger signals released upon oxidative cell injury such as eATP and UA crystals may contribute to NLRP3 inflammasome activation. The cascade of events resulting in NLRP3 activation needs further investigations.

To elucidate the role of ROS, the scavenger N-acetylcysteine (NAC) has been tested in the experimental mouse model. The therapeutic administration of NAC conferred a partial amelioration of ozone-induced inflammation and airway hyperresponsiveness (AHR) [34].

Increased IL-1β expression in the lung upon ozone exposure has been established [43]. Absence of IL-1R1 [24] or neutralisation of IL-1α and IL-1β by the IL-1R antagonist anakinra partially protected from ozone-induced inflammation [43]. However the contribution of IL-1α in ozone-induced lung inflammation has not been established.

Altered functions of human alveolar macrophages upon in vitro exposure to ozone (0.1-1.0 ppm for 2-4) were reported with increased release of prostaglandin E2 (Becker et al. 1991). Alveolar macrophages obtained from guinea pigs and humans exposed to ozone significantly secreted higher levels of cytokines with a peak value at 0.4 ppm for 1 h in the absence of cytotoxicity. IL-1β, IL-6, TNF-α, and IL-8 were increased within 1 h ozone exposure in vitro [3].

Alveolar macrophages accumulate lipids upon cigarette smoke exposure resembling foamy macrophages and release spontaneously the IL-1α and IL-1β cytokines [40]. This was not investigated upon ozone exposure.

Ozone induction of other members of the IL-1 family proteins such as IL-18, IL-33, IL-36 or IL-38 with inflammatory properties have so far not been investigated.

Other inflammatory mediators

The irritant effects of ozone causes the release of a variety of other pro-inflammatory cytokines, chemokines and mediators, which is shortly discussed.

IL-6 is another inflammatory cytokine which is involved in ozone-induced respiratory pathology [26]. Subacute (72 h) exposure to 0.3 ppm ozone with increased protein leak, neutrophils, soluble TNF receptors in BALF were significantly reduced in IL-6- deficient mice, while AHR was not affected.

A recent study on ozone exposure (0.3 ppm for 24-72 h) showed increased neutrophilic inflammation and IL-6 in adiponectin-deficient mice. In adiponectin x IL-6 double deficient mice exposed to ozone, the hyperinflammation was reduced with lower IL-17A and G-CSF expression [28].

IL-10 has known anti-inflammatory properties. Recent data from IL-10 deficient mice suggested increased neutrophil recruitment after low dose ozone (0.3 ppm) at 1 to 3 day with enhanced NF-kB activation and MIP-2, cathepsin E, and serum amyloid A3 gene expression [4]. Therefore, endogenous IL-10 confers partial protection from ozone-induced lung inflammation [4].

TGF-β, transforming growth factor β plays a critical role for the development of fibrosis including chemical induced lung fibrosis [14]. Ozone-induced emphysema and pulmonary fibrosis may be mediated by TGF-β in ozone exposed mice [29]. Chronic ozone exposure (5 day, 0.5 ppm, 8 h/day) for 5 cycles increased TGF-β protein levels in BALF, plasminogen activator inhibitor 1 and lung fibrosis. Blockade of the TGF-β signalling pathway with IN-1233 suppressed ozone-induced Smad2/3 phosphorylation, PAI-1 and collagen expression and α-SMA deposition in the lung. These data suggest that TGF-β signalling mediates ozone-induced lung fibrotic responses. The results are interesting and need to be confirmed using other inhibitors and TGF-β antibodies.

IL-17A is a pro-inflammatory cytokine which is dependent on IL-1R and IL-23R signalling [6,15]. In a 6 weeks ozone exposure model we found increased production of IL-17A and IL-1β, and the activation of p38 MAPK in the lungs which was reduced in IL-17RA deficient mice [48]. Importantly AHR seen after ozone exposure relies on IL-17RA signalling mediated by the increased contractility of airway smooth muscles. The emphysema and lung inflammation induced by ozone however were independent of IL-17RA signalling [48]. By contrast another recent study showed that IL-17A antibody neutralisation reduced the recruitment of neutrophils after subacute ozone exposure (0.3 ppm for 24-72 h) [38]. γδ T cells are an important source of IL-17A. Ozone-induced increases in BAL macrophages, neutrophils and IL-17 were diminished in TCRδ deficient mice. The data indicate that pulmonary inflammation induced by subacute ozone exposure requires γδ T cells and TNFα-dependent recruitment of IL-17A+ γδ T cells to the lung [38].

The role of other IL-17 family members in AHR and lung inflammation is presently unknown. Our preliminary data suggest a protective effect for the related Th17 member, IL-22 which has structural homology with IL-10.

NKT cells: Pichavant et al. demonstrated that ozone induces a form of asthma that occurs in the absence of adaptive immunity characterized essentially by airway neutrophilia, but not eosinophilia, associated with AHR, which is a cardinal feature of asthma [46]. Repeated ozone exposure induced severe AHR associated with an increase of natural killer T (NKT) cells, neutrophils, and macrophages in the airway, which was absent in NKT cell-deficient CD1d(-/-) and Jα18(-/-) mice and was IL-17-dependent [46]. Thus, ozone exposure-induced AHR requires the presence of NKT cells and IL-17 production. Therefore NKT cells are required for the development of two very disparate forms of AHR (ozone- and allergen-induced) and more investigations on the role of NKT cells in ozone pathology may be necessary.

TNF is another fundamental proinflammatory cytokine involved in the biologic response to ozone [12,52,59]. Ozone induces the production of nitric oxide, TNF-α and tissue injury, which is dependent on NF-kB p50 [12].

Furthermore, neutralising TNF-α antibodies reduced protein and neutrophil recruitment in BALF and IL-1α, IL-6 and IL-10 expression upon ozone exposure [7] in animals exposed to O3. Therefore TNF-α is involved in lung inflammation and epithelial injury produced by ozone exposure which is modulated by other cytokines.

CXCR2 is a critical receptor for the neutrophil chemokines KC and macrophage inflammatory protein-2 (MIP-2), which are upregulated in lungs following ozone exposure [25]. Mice deficient for CXCR2 had less protein leak in the BALF and epithelial cell damage suggesting reduced lung injury with diminished AHR as compared to wild-type control mice. Therefore, the role of CXCR2 for maximal neutrophil recruitment, epithelial cell sloughing, and persistent AHR upon ozone exposure should be further explored [25].

Enhanced airway hyperreactivity by ozone resulting in chronic lung disease

Data from epidemiological and experimental studies support a link between air pollution and an increased incidence and/or severity of airway disease. Detrimental effects of ozone, nitrogen dioxide and particulate matter are documented. Recent studies, particularly in urban areas, have suggested a role for pollutants in the development of both asthma and COPD [30].

Preclinical studies may predict and provide supportive data that air environmental pollution by generation of ozone may cause exacerbation of allergic asthma. However as reported before ozone alone causes AHR, a special form of asthma with neutrophilic asthma [46].

Pre-exposure to low dose of endotoxin enhanced the inflammatory response to ozone suggesting sequential and concomitant low doses of injury may result in an exacerbated response [22,23].

The allergic response was investigated in ozone exposed mice [20]. Ozone exposure enhanced allergic asthma with augmented AHR, increased neutrophils and eosinophils in the BALF and lung inflammation with increased numbers of goblet cells, myofibroblasts, and smooth muscle cells [20].

Influenza infection induces AHR through a pathway that required the interleukin 13 (IL-13)-IL-33 axis via innate lymphoid cells 2 (ILC2). Influenza A virus infection activates the NLRP3 inflammasome, resulting in IL-33 production by alveolar macrophages, which in turn activated ILC2 producing substantial IL-13 and enhanced asthma [31]. The data show that respiratory virus infection enhance AHR and whether ozone enhances viral-induced responses needs to be further explored.

There is evidence that several ambient air pollutants enhance the pulmonary fibrotic processes. A recent epidemiological study demonstrated increased ozone and nitrogen dioxide exposure over the preceding 6 weeks was associated with an increased risk of acute exacerbation in patients with idiopathic pulmonary fibrosis [21]. This is clearly an area which needs to be further explored. No studies investigating the role of ozone in exacerbating pulmonary fibrosis are available and this could be tested in the bleomycin model induced lung fibrosis.

Mechanisms and perspective

The present view on the mechanisms of ozone induced lung pathologies can be summarized as shown in Figure 2. Ozone generates ROS which damages the lung epithelial cells, releasing endogenous danger signals, activating the innate immune response notably the NLRP3 inflammasome with release of IL-1. Additional factors including proteases and chemokines are released recruiting inflammatory cells augmenting the local injury response.

Figure 2.

Figure 2

Mechanism of ozone-induced injury, hyperreactivity and inflammation. Ozone generates ROS which damage the lung epithelial cells, activating the innate immune response notably the NLRP3 inflammasome with release of IL-1β. Ozone causes increased permeability by down regulating tight junctions and release of alarmins which are released upon cell necrosis. These events induce chemokines/cytokines production and neutrophils recruitment and inflammation.

In conclusion, this review shows our limited knowledge on the mechanisms of ozone-induced lung inflammation and pathology and its contribution to exacerbation of allergic asthma, viral infection, COPD, pulmonary fibrosis and other respiratory diseases necessitating more mechanistic investigations in addition to a strict control of ozone pollution of the air. Furthermore epidemiological studies are critical to understand the relevance of the preclinical studies.

Acknowledgements

This work has been supported by the funds of Region Centre RespirOzone (N°2014-00091905), CNRS, INSERM and Boehringer Ingelheim. Figures are created and adapted with Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License.

Disclosure of conflict of interest

None.

Abbreviations

LPS

endotoxin

AHR

airway hyperresponsiveness

ROS

reactive oxygen species

HA

hyaluronic acid

TLR4

toll-like receptor 4

ppb

part per billion

PGE2

prostaglandin E2

LTC4

leukotriene C4

PAMP

pathogen associated molecular patterns

DAMP

damage associated molecular patterns

References

  • 1.Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319–325. doi: 10.1016/s1074-7613(04)00046-9. [DOI] [PubMed] [Google Scholar]
  • 2.Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30:556–565. doi: 10.1016/j.immuni.2009.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Arsalane K, Gosset P, Vanhee D, Voisin C, Hamid Q, Tonnel AB, Wallaert B. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am J Respir Cell Mol Biol. 1995;13:60–68. doi: 10.1165/ajrcmb.13.1.7598938. [DOI] [PubMed] [Google Scholar]
  • 4.Backus GS, Howden R, Fostel J, Bauer AK, Cho HY, Marzec J, Peden DB, Kleeberger SR. Protective role of interleukin-10 in ozone-induced pulmonary inflammation. Environ Health Perspect. 2010;118:1721–1727. doi: 10.1289/ehp.1002182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bauer AK, Travis EL, Malhotra SS, Rondini EA, Walker C, Cho HY, Trivedi S, Gladwell W, Reddy S, Kleeberger SR. Identification of novel susceptibility genes in ozone-induced inflammation in mice. Eur Respir J. 2010;36:428–437. doi: 10.1183/09031936.00145309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Besnard AG, Togbe D, Couillin I, Tan Z, Zheng SG, Erard F, Le Bert M, Quesniaux V, Ryffel B. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol. 2012;4:3–10. doi: 10.1093/jmcb/mjr042. [DOI] [PubMed] [Google Scholar]
  • 7.Bhalla DK, Reinhart PG, Bai C, Gupta SK. Amelioration of ozone-induced lung injury by anti-tumor necrosis factor-alpha. Toxicol Sci. 2002;69:400–408. doi: 10.1093/toxsci/69.2.400. [DOI] [PubMed] [Google Scholar]
  • 8.Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A. 2008;105:9035–9040. doi: 10.1073/pnas.0803933105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Cassel SL, Joly S, Sutterwala FS. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol. 2009;21:194–198. doi: 10.1016/j.smim.2009.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Dinarello CA. Interleukin-1beta and the autoinflammatory diseases. N Engl J Med. 2009;360:2467–2470. doi: 10.1056/NEJMe0811014. [DOI] [PubMed] [Google Scholar]
  • 11.Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008;320:674–677. doi: 10.1126/science.1156995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Fakhrzadeh L, Laskin JD, Laskin DL. Ozoneinduced production of nitric oxide and TNFalpha and tissue injury are dependent on NFkappaB p50. Am J Physiol Lung Cell Mol Physiol. 2004;287:L279–285. doi: 10.1152/ajplung.00348.2003. [DOI] [PubMed] [Google Scholar]
  • 13.Feng F, Li Z, Potts-Kant EN, Wu Y, Foster WM, Williams KL, Hollingsworth JW. Hyaluronan activation of the Nlrp3 inflammasome contributes to the development of airway hyperresponsiveness. Environ Health Perspect. 2012;120:1692–1698. doi: 10.1289/ehp.1205188. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 14.Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, Schnyder B, Akira S, Quesniaux VF, Lagente V, Ryffel B, Couillin I. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest. 2007;117:3786–3799. doi: 10.1172/JCI32285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gasse P, Riteau N, Vacher R, Michel ML, Fautrel A, di Padova F, Fick L, Charron S, Lagente V, Eberl G, Le Bert M, Quesniaux VF, Huaux F, Leite-de-Moraes M, Ryffel B, Couillin I. IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis. PLoS One. 2011;6:e23185. doi: 10.1371/journal.pone.0023185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gombault A, Baron L, Couillin I. ATP release and purinergic signaling in NLRP3 inflammasome activation. Front Immunol. 2013;3:414. doi: 10.3389/fimmu.2012.00414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe. 2009;5:487–497. doi: 10.1016/j.chom.2009.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hollingsworth JW, Free ME, Li Z, Andrews LN, Nakano H, Cook DN. Ozone activates pulmonary dendritic cells and promotes allergic sensitization through a Toll-like receptor 4-dependent mechanism. J Allergy Clin Immunol. 2010;125:1167–1170. doi: 10.1016/j.jaci.2010.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9:847–856. doi: 10.1038/ni.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jang AS, Choi IS, Lee JH, Park CS, Park CS. Prolonged ozone exposure in an allergic airway disease model: adaptation of airway responsiveness and airway remodeling. Respir Res. 2006;7:24. doi: 10.1186/1465-9921-7-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014;43:1124–1131. doi: 10.1183/09031936.00122213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Johnston CJ, Holm BA, Finkelstein JN. Sequential exposures to ozone and lipopolysaccharide in postnatal lung enhance or inhibit cytokine responses. Exp Lung Res. 2005;31:431–447. doi: 10.1080/01902140590918605. [DOI] [PubMed] [Google Scholar]
  • 23.Johnston CJ, Oberdörster G, Gelein R, Finkelstein JN. Endotoxin potentiates ozoneinduced pulmonary chemokine and inflammatory responses. Exp Lung Res. 2002;28:419–433. doi: 10.1080/01902140290092029. [DOI] [PubMed] [Google Scholar]
  • 24.Johnston RA, Mizgerd JP, Flynt L, Quinton LJ, Williams ES, Shore SA. Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice. Am J Respir Cell Mol Biol. 2007;37:477–484. doi: 10.1165/rcmb.2006-0315OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Johnston RA, Mizgerd JP, Shore SA. CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am J Physiol Lung Cell Mol Physiol. 2005;288:L61–67. doi: 10.1152/ajplung.00101.2004. [DOI] [PubMed] [Google Scholar]
  • 26.Johnston RA, Schwartzman IN, Flynt L, Shore SA. Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol. 2005;288:L390–397. doi: 10.1152/ajplung.00007.2004. [DOI] [PubMed] [Google Scholar]
  • 27.Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, Taraporewala ZF, Miller D, Patton JT, Inohara N, Núñez G. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem. 2006;281:36560–36568. doi: 10.1074/jbc.M607594200. [DOI] [PubMed] [Google Scholar]
  • 28.Kasahara DI, Kim HY, Mathews JA, Verbout NG, Williams AS, Wurmbrand AP, Ninin FM, Neto FL, Benedito LA, Hug C, Umetsu DT, Shore SA. Pivotal role of IL-6 in the hyperinflammatory responses to subacute ozone in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2014;306:L508–520. doi: 10.1152/ajplung.00235.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Katre A, Ballinger C, Akhter H, Fanucchi M, Kim DK, Postlethwait E, Liu RM. Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice. Inhal Toxicol. 2011;23:486–494. doi: 10.3109/08958378.2011.584919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kelly FJ, Fussell JC. Air pollution and airway disease. Clin Exp Allergy. 2011;41:1059–1071. doi: 10.1111/j.1365-2222.2011.03776.x. [DOI] [PubMed] [Google Scholar]
  • 31.Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, Savage PB, McKenzie AN, Smith DE, Rottman JB, DeKruyff RH, Umetsu DT. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol. 2012;129:216–227. e211–216. doi: 10.1016/j.jaci.2011.10.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137–161. doi: 10.1146/annurev-cellbio-101011-155745. [DOI] [PubMed] [Google Scholar]
  • 33.Last JA, Ward R, Temple L, Kenyon NJ. Ovalbumin-induced airway inflammation and fibrosis in mice also exposed to ozone. Inhal Toxicol. 2004;16:33–43. doi: 10.1080/08958370490258237. [DOI] [PubMed] [Google Scholar]
  • 34.Li F, Wiegman C, Seiffert JM, Zhu J, Clarke C, Chang Y, Bhavsar P, Adcock I, Zhang J, Zhou X, Chung KF. Effects of N-acetylcysteine in ozoneinduced chronic obstructive pulmonary disease model. PLoS One. 2013;8:e80782. doi: 10.1371/journal.pone.0080782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Li Z, Potts-Kant EN, Garantziotis S, Foster WM, Hollingsworth JW. Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP. PLoS One. 2011;6:e27137. doi: 10.1371/journal.pone.0027137. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  • 36.Li Z, Potts EN, Piantadosi CA, Foster WM, Hollingsworth JW. Hyaluronan fragments contribute to the ozone-primed immune response to lipopolysaccharide. J Immunol. 2010;185:6891–6898. doi: 10.4049/jimmunol.1000283. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  • 37.Liang L, Li F, Bao A, Zhang M, Chung KF, Zhou X. Activation of p38 mitogen-activated protein kinase in ovalbumin and ozone-induced mouse model of asthma. Respirology. 2013;18(Suppl 3):20–29. doi: 10.1111/resp.12189. [DOI] [PubMed] [Google Scholar]
  • 38.Mathews JA, Williams AS, Brand JD, Wurmbrand AP, Chen L, Ninin FM, Si H, Kasahara DI, Shore SA. γδ T Cells Are Required for Pulmonary IL-17A Expression after Ozone Exposure in Mice: Role of TNFalpha. PLoS One. 2014;9:e97707. doi: 10.1371/journal.pone.0097707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mauderly JL. Respiratory function responses of animals and man to oxidant gases and to pulmonary emphysema. J Toxicol Environ Health. 1984;13:345–61. doi: 10.1080/15287398409530502. [DOI] [PubMed] [Google Scholar]
  • 40.Morissette MC, Shen P, Thayaparan D, Stämpfli MR. Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice. Eur Respir J. 2015;46:1451–60. doi: 10.1183/09031936.00216914. [DOI] [PubMed] [Google Scholar]
  • 41.Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000;21:1–48. doi: 10.1016/s0098-2997(00)00003-0. [DOI] [PubMed] [Google Scholar]
  • 42.Nawijn MC, Hackett TL, Postma DS, van Oosterhout AJ, Heijink IH. E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol. 2011;32:248–255. doi: 10.1016/j.it.2011.03.004. [DOI] [PubMed] [Google Scholar]
  • 43.Park JW, Taube C, Swasey C, Kodama T, Joetham A, Balhorn A, Takeda K, Miyahara N, Allen CB, Dakhama A, Kim SH, Dinarello CA, Gelfand EW. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol. 2004;30:830–836. doi: 10.1165/rcmb.2003-0373OC. [DOI] [PubMed] [Google Scholar]
  • 44.Pedra JH, Cassel SL, Sutterwala FS. Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol. 2009;21:10–16. doi: 10.1016/j.coi.2009.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pelegrin P, Surprenant A. Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem. 2007;282:2386–2394. doi: 10.1074/jbc.M610351200. [DOI] [PubMed] [Google Scholar]
  • 46.Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff RH, Shore SA, Umetsu DT. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med. 2008;205:385–393. doi: 10.1084/jem.20071507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Pinart M, Hussain F, Shirali S, Li F, Zhu J, Clark AR, Ammit AJ, Chung KF. Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury. Eur J Pharmacol. 2014;744:108–114. doi: 10.1016/j.ejphar.2014.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Pinart M, Zhang M, Li F, Hussain F, Zhu J, Wiegman C, Ryffel B, Chung KF. IL-17A modulates oxidant stress-induced airway hyperresponsiveness but not emphysema. PLoS One. 2013;8:e58452. doi: 10.1371/journal.pone.0058452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Riteau N, Baron L, Villeret B, Guillou N, Savigny F, Ryffel B, Rassendren F, Le Bert M, Gombault A, Couillin I. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 2012;3:e403. doi: 10.1038/cddis.2012.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Riteau N, Gasse P, Fauconnier L, Gombault A, Couegnat M, Fick L, Kanellopoulos J, Quesniaux VF, Marchand-Adam S, Crestani B, Ryffel B, Couillin I. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med. 2010;182:774–783. doi: 10.1164/rccm.201003-0359OC. [DOI] [PubMed] [Google Scholar]
  • 51.Schlingmann B, Molina SA, Koval M. Claudins: Gatekeepers of lung epithelial function. Semin Cell Dev Biol. 2015;42:47–57. doi: 10.1016/j.semcdb.2015.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Shore SA, Williams ES, Chen L, Benedito LA, Kasahara DI, Zhu M. Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1. Inhal Toxicol. 2011;23:878–888. doi: 10.3109/08958378.2011.622316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A. 2011;108:15324–15329. doi: 10.1073/pnas.1100255108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481:278–286. doi: 10.1038/nature10759. [DOI] [PubMed] [Google Scholar]
  • 55.Triantaphyllopoulos K, Hussain F, Pinart M, Zhang M, Li F, Adcock I, Kirkham P, Zhu J, Chung KF. A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. Am J Physiol Lung Cell Mol Physiol. 2011;300:L691–700. doi: 10.1152/ajplung.00252.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179–188. doi: 10.1038/nm.2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wen H, Ting JP, O’Neill LA. A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol. 2012;13:352–357. doi: 10.1038/ni.2228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Williams AS, Leung SY, Nath P, Khorasani NM, Bhavsar P, Issa R, Mitchell JA, Adcock IM, Chung KF. Role of TLR2, TLR4, and MyD88 in murine ozone-induced airway hyperresponsiveness and neutrophilia. J Appl Physiol (1985) 2007;103:1189–1195. doi: 10.1152/japplphysiol.00172.2007. [DOI] [PubMed] [Google Scholar]
  • 59.Zamora ZB, Borrego A, López OY, Delgado R, González R, Menéndez S, Hernández F, Schulz S. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;2005:16–22. doi: 10.1155/MI.2005.16. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Clinical and Experimental Immunology are provided here courtesy of e-Century Publishing Corporation

RESOURCES